{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:58:52Z","timestamp":1792292332118,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.ajkd.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:37:40Z","timestamp":1640947060000},"page":"98-107.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study"],"prefix":"10.1053","volume":"80","author":[{"given":"Flory T.","family":"Muanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Sontrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Fleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.ajkd.2021.11.007_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A\u00a0comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.ajkd.2021.11.007_bib4","series-title":"Opioid Prescribing in Canada: How Are Practices Changing?","year":"2019"},{"issue":"5","key":"10.1053\/j.ajkd.2021.11.007_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain - is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2021.11.007_bib7","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.1503\/cmaj.180599","article-title":"Gabapentin misuse","volume":"191","author":"Lennox","year":"2019","journal-title":"CMAJ"},{"issue":"6","key":"10.1053\/j.ajkd.2021.11.007_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/pm\/pnw351","article-title":"Impact of unrestricted access to pregabalin on the use of opioids and other CNS-active medications: a cross-sectional time series analysis","volume":"18","author":"Kwok","year":"2017","journal-title":"Pain Med"},{"issue":"2","key":"10.1053\/j.ajkd.2021.11.007_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/clpt.1994.118","article-title":"Pharmacokinetics of gabapentin in subjects with various degrees of renal function","volume":"56","author":"Blum","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1053\/j.ajkd.2021.11.007_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"4","key":"10.1053\/j.ajkd.2021.11.007_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.amjmed.2009.09.030","article-title":"Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity","volume":"123","author":"Zand","year":"2010","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2021.11.007_bib12","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2018010096","article-title":"Gabapentin and pregabalin use and association with adverse outcomes among hemodialysis patients","volume":"29","author":"Ishida","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2021.11.007_bib13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.kint.2019.04.033","article-title":"Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States","volume":"96","author":"Waddy","year":"2019","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2021.11.007_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193134","article-title":"Gabapentin dose and the 30-day risk of altered mental status in older adults: a retrospective population-based study","volume":"13","author":"Fleet","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2021.11.007_bib15","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","volume":"2014","author":"Moore","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1053\/j.ajkd.2021.11.007_bib16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/acer.14408","article-title":"Safety of gabapentin prescribed for any indication in a large clinical cohort of 571,718 US veterans with and without alcohol use disorder","volume":"44","author":"Rentsch","year":"2020","journal-title":"Alcoholism Clin Exp Res"},{"issue":"6","key":"10.1053\/j.ajkd.2021.11.007_bib18","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1053\/j.ajkd.2021.11.007_bib19","article-title":"Pregabalin for neuropathic pain in adults","volume":"1","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ajkd.2021.11.007_bib21","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"issue":"12","key":"10.1053\/j.ajkd.2021.11.007_bib22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"issue":"23","key":"10.1053\/j.ajkd.2021.11.007_bib24","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2013.282426","article-title":"Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury","volume":"310","author":"Gandhi","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2021.11.007_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2021.11.007_bib26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","article-title":"Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study","volume":"158","author":"Patel","year":"2013","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1053\/j.ajkd.2021.11.007_bib27","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.2019.17725","article-title":"Association of baclofen with encephalopathy in patients with chronic kidney disease","volume":"322","author":"Muanda","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1053\/j.ajkd.2021.11.007_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2021.11.007_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1681\/ASN.2004080697","article-title":"Network of Eastern Ontario Medical Laboratories (NEO-MeL). Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance","volume":"16","author":"Garg","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2021.11.007_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002369","article-title":"Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Shanthanna","year":"2017","journal-title":"PLoS Med"},{"key":"10.1053\/j.ajkd.2021.11.007_bib33","series-title":"The ICES Practice Atlas","first-page":"339","article-title":"Summary of studies on the quality of health care administrative databases in Canada","author":"Williams","year":"1996"},{"issue":"6","key":"10.1053\/j.ajkd.2021.11.007_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"issue":"5","key":"10.1053\/j.ajkd.2021.11.007_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in nonexperimental research","volume":"6","author":"Brookhart","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1053\/j.ajkd.2021.11.007_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"4","key":"10.1053\/j.ajkd.2021.11.007_bib37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A\u00a0comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"issue":"2","key":"10.1053\/j.ajkd.2021.11.007_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/155.2.176","article-title":"Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology","volume":"155","author":"Hernan","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"28","key":"10.1053\/j.ajkd.2021.11.007_bib39","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"7","key":"10.1053\/j.ajkd.2021.11.007_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A\u00a0modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.11.007_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2021.11.007_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621010489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621010489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:40:53Z","timestamp":1759462853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621010489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0272638621010489"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.11.007","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}